Skip to content
10-Q

Quarterly Report

Neurotrope, Inc.

0001104659-20-123122

← back to feed
Filed
Nov 9, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Nov 5, 2020 23.79M sh
Capex Q3 2020 · Sep 30, 2020 $5.41K
Capex Q3 2020 · Sep 30, 2019 $5.21K
Operating Cash Flow Q3 2020 · Sep 30, 2020 −$6.9M
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$10.37M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $27M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $17.38M
Stockholders Equity Q3 2020 · Sep 30, 2020 $27.85M
Stockholders Equity Q3 2020 · Jun 30, 2020 $29.8M
Stockholders Equity Q3 2020 · Dec 31, 2019 $17.42M
Stockholders Equity Q3 2020 · Sep 30, 2019 $19.12M
Stockholders Equity Q3 2020 · Jun 30, 2019 $21.22M
Stockholders Equity Q3 2020 · Dec 31, 2018 $26.52M
Current Liabilities Q3 2020 · Sep 30, 2020 $1.3M
Current Liabilities Q3 2020 · Dec 31, 2019 $479.06K
Current Assets Q3 2020 · Sep 30, 2020 $29.13M
Current Assets Q3 2020 · Dec 31, 2019 $17.88M
Total Assets Q3 2020 · Sep 30, 2020 $29.15M
Total Assets Q3 2020 · Dec 31, 2019 $17.9M
Sga Expense Q3 2020 · Sep 30, 2020 $1.78M
Sga Expense Q3 2020 · Sep 30, 2020 $5.73M
Sga Expense Q3 2020 · Sep 30, 2019 $2.13M
Sga Expense Q3 2020 · Sep 30, 2019 $5.17M
Rd Expense Q3 2020 · Sep 30, 2020 $410.29K
Rd Expense Q3 2020 · Sep 30, 2020 $1M
Rd Expense Q3 2020 · Sep 30, 2019 $845.8K
Rd Expense Q3 2020 · Sep 30, 2019 $4.27M
Net Income Q3 2020 · Sep 30, 2020 −$4.27M
Net Income Q3 2020 · Sep 30, 2020 −$9.74M
Net Income Q3 2020 · Sep 30, 2019 −$3.82M
Net Income Q3 2020 · Sep 30, 2019 −$12.52M